Company / FCF Margin
Senti Biosciences Holdings, Inc. FCF Margin History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-2515.9%
FY2024
5-year range
-2515.9% / -1455.2%
FY2022-FY2024
Trend
-41.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -1455.2% to -2515.9% over the past 2 years.
Based on SEC 10-K filings.
-2515.9% in FY2024.
Declined from -1455.2% to -2515.9% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, fcf margin decreased 41.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -2515.9% | -41.4% |
| FY2023 | -1779.5% | -22.3% |
| FY2022 | -1455.2% | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026